CommercialAdministrativeLow impact
06.02.45, Vectra® DA Blood Test for Rheumatoid Arthritis
Independence Blue Cross·Rheumatology, Internal Medicine, Family Medicine·Pharmacy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Summary
The Vectra DA Blood Test for Rheumatoid Arthritis policy (06.02.45) has been reissued and updated for commercial plans. This appears to be a routine policy refresh rather than a substantive content change, but billing teams should verify any updates to coverage criteria or documentation requirements.
Action Required
By March 5, 2025: Billing team should review the updated policy at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or documentation standards for Vectra DA testing. Update billing procedures accordingly if substantive changes are identified.